嗜黏蛋白阿克曼菌减轻牙龈卟啉单胞菌诱导的炎症与牙周骨破坏
本研究在瘦和肥胖小鼠中经颅骨脓肿及实验性牙周炎模型给予嗜黏蛋白阿克曼菌,评估其对牙龈卟啉单胞菌诱导炎症的影响。结果显示该菌减少炎症细胞浸润与骨破坏、降低牙槽骨丧失,体外增加IL-10、减少IL-12并上调紧密连接标志物,共培养降低牙龈蛋白酶mRNA表达。提示其可能作为牙周治疗辅助剂。
要点
- 嗜黏蛋白阿克曼菌可减轻牙龈卟啉单胞菌诱导的炎症与牙周骨破坏。
- 体外该菌增加抗炎IL-10、减少IL-12并上调上皮紧密连接标志物。
- 与牙龈卟啉单胞菌共培养可降低牙龈蛋白酶mRNA表达。
核心结论
- 嗜黏蛋白阿克曼菌给药在动物模型中显示保护作用,可能作为牙周治疗的辅助治疗剂。
研究设计与样本
- 在瘦和肥胖小鼠中,于牙龈卟啉单胞菌诱导的颅骨脓肿模型和实验性牙周炎模型中给予嗜黏蛋白阿克曼菌。
- 体外将嗜黏蛋白阿克曼菌与牙龈卟啉单胞菌共培养,并暴露骨髓巨噬细胞和牙龈上皮细胞TIGK进行分析。
主要发现
- 颅骨感染模型中,嗜黏蛋白阿克曼菌减少炎症细胞浸润和骨破坏。
- 实验性牙周炎模型中,嗜黏蛋白阿克曼菌治疗导致牙槽骨丧失减少。
- 体外共培养时,嗜黏蛋白阿克曼菌增加抗炎IL-10并减少IL-12。
- 嗜黏蛋白阿克曼菌暴露增加TIGK细胞中整合素β1、E-钙黏蛋白和ZO-1等连接完整性标志物的表达。
- 嗜黏蛋白阿克曼菌与牙龈卟啉单胞菌共培养降低牙龈蛋白酶mRNA表达。
临床怎么用
- 提示嗜黏蛋白阿克曼菌可能作为牙周治疗的辅助治疗剂,但需进一步临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: Akkermansia muciniphila is a beneficial gut commensal, whose anti-inflammatory properties have recently been demonstrated. This study aimed to evaluate the effect of A. muciniphila on Porphyromonas gingivalis elicited inflammation. MATERIAL AND METHODS: In lean and obese mice, A. muciniphila was administered in P. gingivalis-induced calvarial abscess and in experimental periodontitis model (EIP). Bone destruction and inflammation were evaluated by histomorphometric analysis. In vitro, A. muciniphila was co-cultured with P. gingivalis, growth and virulence factor expression was evaluated. Bone marrow macrophages (BMMϕ) and gingival epithelial cells (TIGK) were exposed to both bacterial strains, and the expression of inflammatory mediators, as well as tight junction markers, was analysed. RESULTS: In a model of calvarial infection, A. muciniphila decreased inflammatory cell infiltration and bone destruction. In EIP, treatment with A. muciniphila resulted in a decreased alveolar bone loss. In vitro, the addition of A. muciniphila to P. gingivalis-infected BMMϕ increased anti-inflammatory IL-10 and decreased IL-12. Additionally, A. muciniphila exposure increases the expression of junctional integrity markers such as integrin-β1, E-cadherin and ZO-1 in TIGK cells. A. muciniphila co-culture with P. gingivalis reduced gingipains mRNA expression. DISCUSSION: This study demonstrated the protective effects of A. muciniphila administration and may open consideration to its use as an adjunctive therapeutic agent to periodontal treatment.
引用
- Huck O, Mulhall H, Rubin G, et al. Akkermansia muciniphila reduces Porphyromonas gingivalis-induced inflammation and periodontal bone destruction. J Clin Periodontol. 2019. PMID: 31674689. doi:10.1111/jcpe.13214
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。